Humer Franz B
SEC CIK 1548072 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | Dir | 307.5K | — | $46.1K | 5 | 2022-06-15 | 2024-12-05 |
Most active insiders at ALLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chang David D | Pres, CEO, Dir | — | $289.5K |
| 2 | Roberts Zachary | EVP of R, D | — | $104.2K |
| 3 | Douglas Earl Martin | SVP, GC | — | $103.3K |
| 4 | Parker Geoffrey M. | CFO | — | $88.5K |
| 5 | Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| 6 | Yoshiyama Annie | SVP, Fin | — | $29.3K |
| 7 | Kazam Joshua A | Dir | — | — |
Humer Franz B made no open-market trades at ALLO in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-09 | 2024-12-05 | ALLO | Allogene Therapeutics, Inc. | Humer Franz B | Dir | S - Sale | $2.16 | -9,221 | 307.5K | -3% | -$19.9K | |
| D | 2024-06-07 | 2024-06-05 | ALLO | Allogene Therapeutics, Inc. | Humer Franz B | Dir | A - Grant | $0.00 | +61.5K | 316.7K | +24% | $0 |
| 2024-06-03 | 2024-05-30 | ALLO | Allogene Therapeutics, Inc. | Humer Franz B | Dir | S - Sale | $2.34 | -11.2K | 255.3K | -4% | -$26.2K | |
| 2023-06-15 | 2023-06-13 | ALLO | Allogene Therapeutics, Inc. | Humer Franz B | Dir | A - Grant | $0.00 | +74.6K | 266.5K | +39% | $0 | |
| 2022-06-17 | 2022-06-15 | ALLO | Allogene Therapeutics, Inc. | Humer Franz B | Dir | A - Grant | $0.00 | +44.2K | 191.9K | +30% | $0 |
Purchase Sale Sale after option exercise All abbreviations